DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942 | +11.6% | 63,800 | -2.4% | 0.00% | 0.0% |
| Q2 2023 | $844 | -60.5% | 65,400 | -70.0% | 0.00% | +33.3% |
| Q1 2023 | $2,139 | +193.8% | 218,100 | +218.4% | 0.00% | 0.0% |
| Q4 2022 | $728 | -99.9% | 68,500 | -8.3% | 0.00% | -25.0% |
| Q3 2022 | $779,000 | -15.5% | 74,700 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $922,000 | +236.5% | 73,300 | +189.7% | 0.00% | +300.0% |
| Q1 2022 | $274,000 | -22.8% | 25,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $355,000 | -27.0% | 25,300 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $486,000 | – | 25,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |